Evidence map›Paper›PMID 39768116›Full record

ArticleBioengineering (Basel, Switzerland)2024

Development of a Microfluidic Viscometer for Non-Newtonian Blood Analog Fluid Analysis.

Yii-Nuoh Chang, Da-Jeng Yao

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yii-Nuoh ChangInstitute of NanoEngineering and MicroSystems, National Tsing Hua University, Hsinchu City 300, Taiwan.
Da-Jeng YaoInstitute of NanoEngineering and MicroSystems, National Tsing Hua University, Hsinchu City 300, Taiwan.ORCID 0000-0001-6631-780X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of stroke is on the rise globally. This affects one in every four individuals each year, underscoring the urgent need for early warning and prevention systems. The existing research highlights the significance of monitoring blood viscosity in stroke risk evaluations. However, the current methods lack the precision to measure viscosity under low shear rate conditions (<100 s⁻¹), which are observed during pulsatility flow. This study addresses this gap by introducing a novel microfluidic platform designed to measure blood viscosity with high precision under pulsatility flow conditions. The systolic blood viscosity (SBV) and diastolic blood viscosity (DBV) can be differentiated and evaluated by using this system. The non-Newtonian behavior of blood is captured across specific shear rate conditions. The platform employs a meticulously designed microarray to simulate the variations in blood viscosity during pulsation within blood vessels.The results demonstrate an impressive accuracy of 95% and excellent reproducibility when compared to traditional viscometers and rheometers and are within the human blood viscosity range of 1-10 cP. This monitoring system holds promise as a valuable addition to stroke risk evaluation methods, with the potential to enhance prediction accuracy.

Indexed as

blood behavior flowmicrofluidic devicenon-Newtonian fluid

Identifiers

PMID39768116
PMCPMC11727371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.